Foghorn reported $267.4 million in cash and equivalents as of September 30, 2024, which is expected to fund operations into ...

One stage of drug development is testing on lab-grown cell cultures, which are usually grown on a flat surface, like a microscope slide. However, printing cells in 3D can potentially make tests ...

the drug remains in development for multiple sclerosis. "We remain deeply committed to fully understanding the effects of DNL343 in ALS and will further evaluate the data before determining next ...